Background Insulin resistance is associated with the incidence of diabetes and
cardiovascular diseases such as myocardial infarction. The ratio of triglycerides (TG) to high …

Hyperlipidemia, a common metabolic disease, is a risk factor for cardiovascular diseases,
Poria cocos (PC) and Alismatis rhizoma (AR) serve as a potential treatment. A systematic …

Menopause is associated with adverse cardiometabolic changes which increase the risk of
new-onset type 2 diabetes (T2DM) and cardiovascular disease (CVD). Statins are widely …

Background To investigate the efficacy and safety of moderate-intensity
rosuvastatin/ezetimibe combination compared to highintensity rosuvastatin in high …

Statin is the medication most widely prescribed to reduce plasma cholesterol levels. Yet,
how the medication contributes to diabetes risk and impaired glucose metabolism is not …

The reported beneficial effects of statins on cardiovascular outcome based on risk
assessment are inconsistent. Therefore, we investigated statin therapy effectiveness for the …

Background Proteinuria has been recognized as a marker of systemic inflammation and
endothelial dysfunction associated with insulin resistance and β-cell impairment, which can …

Background: While statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors)
reduce cardiovascular morbidity and mortality, there is controversy regarding a potentially …

Statins are widely prescribed lipid-lowering agents used for the prevention of cardiovascular
diseases. However, several clinical trials and meta-analyses have reported that statin use is …

What is known and objectives Regardless of statin use, which is known to induce
hyperglycaemia, comparative studies on the risk of new‐onset diabetes mellitus (NODM) …